scopejointaction

SCOPE, funded by the Health Programme of the EU, developed tools to support the EU #pharmacovigilance network. All tweets represents the project as a whole.

[MHRAgovuk @MHRAgovuk]

#medsafetyweek starts today! 32 medicines regulators around the globe join forces to encourage reporting side effects to medicines in children and pregnancy. Watch out for our tweets, join the conversation, and help us spread the word! Find out more: https://t.co/BdimyAB98K

[MHRAgovuk @MHRAgovuk]

Reporting side effects can lead to new warnings for patients, making medicines safer for everyone. See how reporting helps us all stay healthy and help us spread the word! #medsafetyweek #reportsideeffects #patientsafety #ADRawareness https://t.co/BdimyAB98K

[Nitin Joshi @DrugSafetyJ]

@EU_SCOPE article: "Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network : The SCOPE Joint Action" now published in Drug Safety #openaccess #Pharmacovigilance
https://t.co/BMWo0V8VAv

[WEBRADR @WEBRADR]

.@WEBRADR is celebrating 10 years of medical innovation at the #IMITenYears celebration! @IMI_JU @EU_Commission #IMICarryTheTorch #EUHealthResearch

[scopejointaction @EU_SCOPE]

SCOPE article, 'Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study' was published in #DrugSafety! #pharmacovigilance #safetycommunication

[scopejointaction @EU_SCOPE]

.@EU_SCOPE will have a stand at the @medicinesforEU #pharmacovigilance conference @landmarklondon on 24 January 2018 https://t.co/PyptJCPnoQ #SCOPEJointAction

[MHRAgovuk @MHRAgovuk]

Reporting side effects can lead to new warnings for patients. See the positive impact of reporting: https://t.co/FPEv085ih3
Report side effects to us: https://t.co/HjjWaiBmdD

[MHRAgovuk @MHRAgovuk]

Reporting suspected side effects improves medicines safety. Watch our video to find out more #patientsafety https://t.co/Q7izBMKmFv

[MHRAgovuk @MHRAgovuk]

Think you've got a side effect? Read the medicines leaflet, speak to your Dr & let us know! #PatientSafety: https://t.co/fyPQsvf1kn

[WEBRADR @WEBRADR]

Come and learn more about @IMI_JU @WEBRADR at #ISoP2017 stand 4 @ISoPonline

[scopejointaction @EU_SCOPE]

Come and learn about @EU_SCOPE at @ISoPonline poster stand 95 #ISoP2017

[WEBRADR @WEBRADR]

View the agenda! @WEBRADR stakeholder event #WEBRADR2017 https://t.co/dlhCYBpFqt #pharmacovigilance #socialmedia #sustainability #mhealth

[scopejointaction @EU_SCOPE]

.@EU_SCOPE #ADRreporting #socialmedia article @UMCGlobalSafety #UppsalaReports 75 https://t.co/sWXCxmhspf #pharmacovigilance

[scopejointaction @EU_SCOPE]

.@EU_SCOPE #ADRreporting #socialmedia article @UMCGlobalSafety #UppsalaReports 75 https://t.co/sWXCxmhspf #pharmacovigilance

[WEBRADR @WEBRADR]

.@WEBRADR stakeholder event #WEBRADR2017 theme 2 speakers include Stephanie Bodin-Parssinen, UCB, @UMCG's Peter Mol and Linda Harmark #LAREB

[WEBRADR @WEBRADR]

.@MHRAgovuk's Dr June Raine will open the #WEBRADR2017 stakeholder event alongside Colm Carroll from @IMI_JU @WEBRADR #pharmacovigilance

[WEBRADR @WEBRADR]

Sustainability of @IMI_JU @WEBRADR project and future opportunities to be discussed under theme 3 at the stakeholder event #WEBRADR2017

[WEBRADR @WEBRADR]

.@WEBRADR stakeholder event theme 4: maximising the value of #mobilehealth in the new vigilance world #pharmacovigilance #WEBRADR2017

[WEBRADR @WEBRADR]

.@WEBRADR Theme 1 speakers: @Niklas_Noren @UMCGlobalSafety, Simon Maskell @LivUni, John van Stekelenborg @JanssenUS & @EMA_News #WEBRADR2017

[WEBRADR @WEBRADR]

.@WEBRADR @IMI_JU ADR reporting #mobileapp article @UMCGlobalSafety #UppsalaReports 76 https://t.co/X2dSmq1fbE #pharmacovigilance #mhealth